Trials / Completed
CompletedNCT01004835
The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 61 (actual)
- Sponsor
- Scripps Translational Science Institute · Academic / Other
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to obtain blood or saliva samples to define genes for migraine and pain diseases.
Detailed description
It is estimated that over one-third of the world's population suffers from persistent or recurrent pain. Migraine is highly heritable and the majority of juveniles who suffer from the disorder have a mother or father who also have the disease. The blood or saliva samples will go through DNA analysis and be sequenced for candidate genes or subjected to whole-genome sequencing. By creating a MAPS GeneBank from these patients' blood/saliva donations we will ultimately be able to define genes for migraine and pain diseases.
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2009-10-30
- Last updated
- 2015-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01004835. Inclusion in this directory is not an endorsement.